港股异动 | 礼邦医药-B(09637.HK)涨超8% AP308治疗IgAN新药申请获FDA批准 已于肾脏医学领域验证治疗潜力

智通财经
Sep 21
【港股异动 | 礼邦医药-B(09637.HK)涨超8% AP308治疗IgAN新药申请获FDA批准 已于肾脏医学领域验证治疗潜力】智通财经APP获悉,礼邦医药-B(09637.HK)涨超8%,截至发稿,涨8.18%,报27.5港元,成交额1286.21万港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10